Lancaster Laboratories appoints biologics expert


Jeri Ann Boose joins the company

Biologics expert Jeri Ann Boose has joined Lancaster Laboratories, part of Thermo Fisher Scientific, as director of biopharmaceutical services.

Boose will provide strategic, scientific and regulatory direction for the company’s rapidly expanding biopharmaceutical testing business, which includes biochemistry, cell and molecular biology and virology capabilities. She has expertise in the formulation of global regulatory product testing strategies and in the preparation of global regulatory filings, as well as commercialisation of new products for biopharmaceutical customers.

‘The combination of Dr Boose’s renowned expertise in biologics, coupled with our comprehensive biopharmaceutical capabilities, clearly positions Lancaster Laboratories as a leading provider of services to support the development and commercialisation of biologics products,’ said Timothy Oostdyk, executive vice president and chief operating officer of Lancaster Laboratories.

Features Companies